What is CorMedix's quick ratio?

CorMedix (CRMD) reported quick ratio of 2.7× in Q1 2026.

How has CorMedix's quick ratio changed year-over-year?

CorMedix's quick ratio decreased by 31.5% year-over-year, from 4× to 2.7×.

What is the long-term trend for CorMedix's quick ratio?

Over 5 years (2020 to 2025), CorMedix's quick ratio has grown at a -30.0% compound annual growth rate (CAGR), from 11.5× to 1.9×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

CorMedix CRMD Quick ratio

Quick ratio at other companies

PfizerPFE

1.2×0.0×

Merck & Co.MRK

1.1×-0.2×

Merit Medical SystemsMMSI

3.5×+0.2×

ITG

Integer HoldingsITGR

2.4×+0.2×

IAR

Integra LifeSciencesIART

2×+1.2×

Emergent BiosolutionsEBS

2.1×-1.4×

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

quick assets/total current liabilities=2.7×

Based on the most recent quarter.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's quick ratio?: CorMedix (CRMD) reported quick ratio of 2.7× in Q1 2026.
How has CorMedix's quick ratio changed year-over-year?: CorMedix's quick ratio decreased by 31.5% year-over-year, from 4× to 2.7×.
What is the long-term trend for CorMedix's quick ratio?: Over 5 years (2020 to 2025), CorMedix's quick ratio has grown at a -30.0% compound annual growth rate (CAGR), from 11.5× to 1.9×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.